AspirinThird Party Manufacturing in India

Aspirin, chemically known as acetylsalicylic acid, works by irreversibly inhibiting the cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) enzymes. These enzymes are responsible for converting arachidonic acid into prostaglandins, which are key chemical mediators of inflammation, pain, and fever. By blocking prostaglandin synthesis, Aspirin effectively reduces swelling, pain perception, and body temperature during a febrile response. In addition to its anti-inflammatory properties, Aspirin plays a crucial role in cardiovascular health through its antiplatelet effect. At low doses, it selectively and irreversibly inactivates the COX-1 enzyme in blood platelets. This blockade stops the synthesis of thromboxane A2, a lipid that normally promotes platelet aggregation and vasoconstriction. Because platelets cannot synthesize new enzymes during their lifespan, this antiplatelet effect lasts for the remaining life of the platelet (approximately 7 to 10 days), thereby preventing blood clots. Unlike standard NSAIDs which bind reversibly, Aspirin's irreversible binding provides sustained protective benefits against ischemic events. It is widely tolerated and crucial for secondary cardiovascular prevention.

Therapeutic Uses

Aspirin is prescribed for:

• Cardiovascular Prevention: Reducing the risk of myocardial infarction (heart attack) and stroke in patients with high-risk cardiovascular disease or established history of vascular events.
• Angina Management: Managing symptoms and preventing complications in patients diagnosed with stable or unstable angina pectoris.
• Post-Procedural Prophylaxis: Preventing blood clots in patients who have undergone coronary artery bypass graft (CABG), percutaneous transluminal coronary angioplasty (PTCA), or vascular stenting.
• Mild-to-Moderate Pain Relief: Alleviating minor aches, pains, headaches, and reducing fever in higher dosage forms.

Why Manufacturers Choose Aspirin

Aspirin remains one of the most commercially significant and widely produced pharmaceutical active ingredients in the world. The low-dose 75mg formulation is a standard daily maintenance drug recommended by global cardiovascular guidelines, guaranteeing a stable, high-volume market with continuous repeat purchases. For third-party manufacturing partners, Aspirin is an essential anchor product that strengthens their cardiovascular and primary care portfolios. The formulation of enteric-coated (gastro-resistant) or dispersible tablets requires precise processing to ensure active ingredient protection and uniform dissolution. Indian manufacturers utilize advanced wet granulation and fluid-bed coating technologies to produce tablets that meet stringent IP, BP, and USP standards. This ensures high-quality supply chains for domestic PCD franchise networks and large-scale export orders.

This makes Aspirin one of the most sought-after cardiovascular formulations for third party manufacturing in India, with consistent demand from cardiac care brands and international exporters.